Catalyst Wire Dossier Catalyst Wire Dossier

Fasinumab

fasinumab · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Fasinumab, covering 2016-05-12 to 2023-10-13. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip [Phase 3]

See pricing